Athérothrombose : transposition des modèles à la clinique et réciproquement
Tài liệu tham khảo
Cazenave, 1983, L’agrégation plaquettaire: outil d’investigation clinique et d’étude pharmacologique. Méthodologie, Ann Biol Clin, 41, 167
Boneu, 1997, Introduction à l’étude de l’hémostase et de la thrombose
Leon, 1997, The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells, FEBS Lett, 403, 26, 10.1016/S0014-5793(97)00022-7
Hechler, 1998, The P2Y1 receptor is necessary for adenosine 5’-diphosphate-induced platelet aggregation, Blood, 92, 152, 10.1182/blood.V92.1.152.413k27_152_159
Nonne, 2005, Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity, Arterioscler Thromb Vasc Biol, 25, 1293, 10.1161/01.ATV.0000163184.02484.69
Mizuno, 1992, Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes, N Engl J Med, 326, 287, 10.1056/NEJM199201303260502
TIMI IIIb Trial, 1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545
Lanza, 2000, La glycoprotéine V: un substrat plaquettaire de la thrombine marqueur des thromboses et de la différenciation mégacaryocytaire, Hématologie, 6, 424
Aleil, 2004, La glycoprotéine V soluble: un nouveau marqueur plasmatique de la thrombose artérielle, MT cardiologie, 2, 267
